(Reuters) - Pharmaceutical giant Novo Nordisk said on Tuesday it would invest millions in Iran, joining a still very small group of European companies to have announced concrete deals in Tehran after it struck a deal on its nuclear programme.
Novo Nordisk, the world's largest diabetes drugs maker, said it would build a 70 million euro ($78 million) manufacturing plant in Iran. It already has a subsidiary in the country selling insulin and employing 130 people there since 2005.
Help employers find you! Check out all the jobs and post your resume.
Novo Nordisk, the world's largest diabetes drugs maker, said it would build a 70 million euro ($78 million) manufacturing plant in Iran. It already has a subsidiary in the country selling insulin and employing 130 people there since 2005.
Help employers find you! Check out all the jobs and post your resume.
